✦ LIBER ✦

Onset and duration of hypoalgesia of lidocaine spray applied to oral mucosa – a dose response study

✍ Scribed by N. K. Schønemann; M. van der Burght; L. Arendt-Nielsen; P. Bjerring

Book ID: 115104161
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 235 KB
Volume: 36
Category: Article
ISSN: 0001-5172
DOI: 10.1111/j.1399-6576.1992.tb03554.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of whey proteins on glycaemia an

Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose–response study

✍ Gunnerud, U J; Östman, E M; Björck, I M E 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 848 KB

A randomized, double-blind, parallel-gro

A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species

✍ J. Lipozencic; M. Skerlev; R. Orofino-Costa; V.C. Zaitz; A. Horvath; E. Chouela; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

A prospective, randomized study of cryot

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

✍ Maloney, D G; Press, O W; Bensinger, W; Lilleby, K; Garcia, P; Gooley, T; McDonn 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

70 A Randomized, Double-Blind, Placebo-C

70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis

✍ Barton, Matthew E.; Otiker, Tal; Johnson, Lakshmi Vasist; Robertson, Darren C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A phase IIb dose-ranging study of the or

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

✍ Joel M. Kremer; Stanley Cohen; Bethanie E. Wilkinson; Carol A. Connell; Jonathan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 4 views